Post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite in exhaled breath: pharmacokinetic models for assessing liver function
Authors:
- F Di FrancescoF Di Francesco
- M OnorMOM Onor
- M A StiegelMSM A Stiegel
- M G TrivellaM G Trivella
- C ComiteCCC Comite
- N CataniaNCN Catania
- R FuocoRFR Fuoco
- J D PleilJPJ D Pleil
- 5 June 2013
- journal article
- Published by IOP Publishing in Journal of Breath Research
- Vol. 7 (3) , 036001
Abstract
Sevoflurane (SEV), a commonly used anesthetic agent for invasive surgery, is directly eliminated via exhaled breath and indirectly by metabolic conversion to inorganic fluoride and hexafluoroisopropanol (HFIP), which is also eliminated in the breath. We studied the post-operative elimination of SEV and HFIP of six patients that had undergone a variety of surgeries lasting between 2.5 to 8.5 h using exhaled breath analysis. A classical three compartments pharmacokinetic model developed for the study of environmental contaminants was fitted to the breath data. We found that SEV kinetic behavior following surgery (for up to six days) is consistent across all subjects whereas the production and elimination of HFIP varies to some extent. We developed subject specific parameters for HFIP metabolism and interpreted the differences in the context of timing and dose of anesthesia, type of surgery, and specific host factors. We propose methods for assessing individual patient liver function using SEV as a probe molecule for assessing efficiency of liver metabolism to HFIP. This work is valuable not only for the clinical study of metabolism recovery, but potentially also for the study of the interaction of other manufactured and environmental compounds with human systems biology in controlled exposure and observational studies.Keywords
This publication has 25 references indexed in Scilit:
- Physiological and Biochemical Basis of Clinical Liver Function TestsAnnals of Surgery, 2013
- Strategies for evaluating the environment–public health interaction of long-term latency disease: The quandary of the inconclusive case–control studyChemico-Biological Interactions, 2012
- Reconstructing Human Exposures Using Biomarkers and other “Clues”Journal of Toxicology and Environmental Health, Part B, 2012
- Role of Exhaled Breath Biomarkers in Environmental Health ScienceJournal of Toxicology and Environmental Health, Part B, 2008
- L-[1- 13 C] phenylalanine breath test for monitoring hepatic function after living donor liver transplant surgeryJournal of Breath Research, 2007
- Extrahepatic Metabolism by CYP2E1 in PBPK Modeling of Lipophilic Volatile Organic Chemicals: Impacts on Metabolic Parameter Estimation and Prediction of Dose MetricsJournal of Toxicology and Environmental Health, Part A, 2007
- CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modelingArchives of Biochemistry and Biophysics, 2007
- Early postoperative erythromycin breath test measures hepatic CYP3A4-activity and predicts graft function in liver transplant recipientsJournal of Hepatology, 2001
- Alveolar breath sampling and analysis to assess trihalomethane exposures during competitive swimming training.Environmental Health Perspectives, 1997
- Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and MethoxyfluraneAnesthesiology, 1993